Y. Kawaguchi

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study

M. Nangaku, Y. Komatsu, K. Ueta, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long‐term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus

N. Inagaki, K. Kaku, S. Harashima, 2017, Diabetes, obesity & metabolism.

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

N. Inagaki, S. Harashima, Y. Kawaguchi, 2016, Cardiovascular Diabetology.

Efficacy and safety of canagliflozin as add‐on therapy to a glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week, open‐label, phase IV study

N. Inagaki, S. Harashima, Makiko Otsuka, 2018, Diabetes, obesity & metabolism.

Real‐world safety of the novel, free radical scavenger edaravone for amyotrophic lateral sclerosis patients: Data from the post‐marketing surveillance SUNRISE Japan

G. Sobue, S. Yuki, Kengo Yoshida, 2021, Neurology and Clinical Neuroscience.

Title Long-term efficacy and safety of canagliflozin in combinationwith insulin in Japanese patients with type 2 diabetes mellitus

K. Kaku, S. Harashima, K. Kondo, 2018 .

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan

M. Nangaku, Y. Komatsu, K. Ueta, 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial

M. Jardine, T. Wada, K. Arakawa, 2021, Journal of Diabetes Investigation.

A phase 3, open‐label, single‐arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis‐stimulating agents

M. Nangaku, Y. Komatsu, K. Ueta, 2021, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD

M. Nangaku, Y. Komatsu, K. Ueta, 2021, Journal of the American Society of Nephrology : JASN.

Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.

S. Madhi, M. Couture, T. Polasek, 2021, Vaccine.